Online Program Home
My Program

CC = Colorado Convention Center   H = Hyatt Regency Denver at Colorado Convention Center
* = applied session       ! = JSM meeting theme

Activity Details

339 Tue, 7/30/2019, 10:30 AM - 12:20 PM CC-105
SPEED: Biopharmaceutical and General Health Studies: Statistical Methods and Applications, Part 1 — Contributed Speed
Biopharmaceutical Section, Section on Statistics in Epidemiology, Section on Bayesian Statistical Science, Health Policy Statistics Section, ENAR
Chair(s): Sedigheh Mirzaei Salehabadi, St. Jude Children's Research Hospital
Poster Presentations for this session.
10:35 AM Mediation Analysis for Longitudinal Data with Applications to Clinical Trial Data
Yun Zhang
10:40 AM Adjusting Response Adaptive Allocation for Subject Dropout

Katharine Stromberg, Virginia Commonwealth University; Adam Sima, Virginia Commonwealth University
10:45 AM The Use of a New Classifier to Maximize the Classification Performance

Hua Ma, Merck; Joe Heyse, Merck
10:50 AM Reproducibility of Living Data - Validation of Published Research Using the Parkinson’s Progression Marker Initiative Living Database
Elliot Burghardt, University of Iowa; Christopher Coffey, University of Iowa; Chelsea Caspell-Garcia, University of Iowa; Eric Foster, Ferring Pharmaceuticals
10:55 AM Blinding in Open Label Study with Adaptive Design

Bo Xu, Boston Biomedical Inc; Bo Jin, Boston Biomedical Inc; Alex Dmitrienko, Mediana Inc
11:00 AM Estimating the Relative Risk for Response-Biased Samples: Calibration and Conditional Likelihood

Claudia Rivera-Rodriguez, University of Auckland
11:05 AM Another Estimation Method Besides MMRM for Treatment Effects in Diabetes Clinical Trials

Yu Du, Eli Lilly and Company
11:10 AM Criteria for Choosing a Futility Method for Clinical Studies

Richard McNally, Covance-Chiltern
11:15 AM Random Forests for Exploring Factors Driving Opioid Prescribing in National Outpatient Health Care Data Using Complex Survey Design

Yong Ma, FDA; JaeJoon Song, FDA
11:20 AM An Adaptive Phase II Dose Finding Study Using Sample Size Re-Estimation Design
Qingyang Liu, University of Connecticut; Guanyu Hu, University of Connecticut; Yaoshi Wu, Boehringer-Ingelheim ; Binqi Ye, Boehringer-Ingelheim; Susan Wang, Boehringer-Ingelheim
11:30 AM Sieve Maximum Likelihood Method for Interval-Censored Data with Missing Covariates Under Proportional Hazards Model
Ruiwen Zhou, University of Missouri-Columbia; Huiqiong Li, Yunnan University; (Tony) Jianguo Sun, University of Missouri
11:35 AM Quantifying the Number of Events Borrowed from External Data in Hybrid Control Arms

Brian Segal, Flatiron Health; Carrie Bennette, Flatiron Health; Somnath Sarkar, Flatiron Health
11:40 AM Characterizing Irreproducibility in Drug Sensitivity Data from a Large Pharmacogenomic Study
Zoe Rehnberg, University of Michigan; Johann A Gagnon-Bartsch, University of Michigan
11:45 AM Closest Similar Subset Imputation
Macaulay Okwuokenye, Brio Dexteri Pharmaceutical Consultant & UNE; Karl E Peace, Georgia Southern University
11:50 AM Planning and Analyzing Clinical Trials with Competing Risks: Recommendations for Choosing Appropriate Statistical Methodology

Misun Yu Lee, Astellas Pharma; Joseph Poythress, University of Georgia; James Young, Astellas Pharma
11:55 AM Estimating and Using the Attained Power Distribution to Ensure We Get the Trial Power We Expect
Yongdong Ouyang, University of British Columbia; Hubert Wong, University of British Columbia; Ehsan Karim, University of British Columbia; Paul Gustafson, University of British Columbia
12:00 PM Bayesian Semiparametric Joint Modeling of Longitudinal Predictors and a Binary Outcome

Woobeen Lim, The Ohio State University; Michael Pennell, Ohio State University
12:05 PM Clustering of Multivariate Data with Varying Dimensions

Xiaoqi Lu, Columbia University; Bin Cheng, Columbia University; Ying Kuen Ken Cheung, Columbia University
12:10 PM Floor Discussion